Pharmacogenetics: implementing personalized medicine

Por Mini, Enrico, Nobili, Stefania
Publicado em 2009

Editorial: Multidrug Resistance in Cancer: Pharmacological Strategies from Basic Research to Clinical Issues

Por Riganti, Chiara, Mini, Enrico, Nobili, Stefania
Publicado no Front Oncol (2015)

Genomic and genetic alterations influence the progression of gastric cancer

Por Nobili, Stefania, Bruno, Lorenzo, Landini, Ida, Napoli, Cristina, Bechi, Paolo, Tonelli, Francesco, Rubio, Carlos A, Mini, Enrico, Nesi, Gabriella
Publicado em 2011

In vitro assessment of antibody-conjugated gold nanorods for systemic injections

Por Centi, Sonia, Tatini, Francesca, Ratto, Fulvio, Gnerucci, Alessio, Mercatelli, Raffaella, Romano, Giovanni, Landini, Ida, Nobili, Stefania, Ravalli, Andrea, Marrazza, Giovanna, Mini, Enrico, Fusi, Franco, Pini, Roberto
Publicado no J Nanobiotechnology (2014)

Genotype-Driven Phase I Study of Irinotecan Administered in Combination With Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer

Por Toffoli, Giuseppe, Cecchin, Erika, Gasparini, Giampiero, D'Andrea, Mario, Azzarello, Giuseppe, Basso, Umberto, Mini, Enrico, Pessa, Sergio, De Mattia, Elena, Lo Re, Giovanni, Buonadonna, Angela, Nobili, Stefania, De Paoli, Paolo, Innocenti, Federico
Publicado no J Clin Oncol (2010)

HLA-G 3’UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment

Por Garziera, Marica, Bidoli, Ettore, Cecchin, Erika, Mini, Enrico, Nobili, Stefania, Lonardi, Sara, Buonadonna, Angela, Errante, Domenico, Pella, Nicoletta, D’Andrea, Mario, De Marchi, Francesco, De Paoli, Antonino, Zanusso, Chiara, De Mattia, Elena, Tassi, Renato, Toffoli, Giuseppe
Publicado no PLoS One (2015)

Gastrointestinal Cancers and Personalized Medicine

Publicado em 2022